AACE Algorithm Offers New Guidance on Managing T2DM

How Does It Compare With ADA/EASD Guidelines?

Anne L. Peters, MD, CDE


May 31, 2013

This feature requires the newest version of Flash. You can download it here.
In This Article

Position Statements vs Algorithms for Type 2 Diabetes

Hi. I am Dr. Anne Peters from the University of Southern California. Today I will take on the difficult task of comparing the American Association of Clinical Endocrinologists (AACE) algorithms for the treatment of type 2 diabetes[1] with the position statement of the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) for the management of hyperglycemia in type 2 diabetes.[2]

In fairness, I will disclose that I was one of the authors of the ADA/EASD position statement. I have biases, but I also know the process by which algorithms are created. Thus, I have some insider information to use when evaluating these statements. Furthermore, it is difficult to compare them while using the terms "algorithm," "position statement," and "guidelines" correctly. The ADA/EASD document is a position statement, which means that it is not meant to be an algorithm or a guideline. The AACE document is a series of algorithms with very minimal text; it delineates the treatment of all elements of type 2 diabetes, (hyperglycemia, obesity, prediabetes, hypertension, and dyslipidemia). The ADA/EASD position statement looks only at the treatment of hyperglycemia in type 2 diabetes. I will focus first on that position statement and then I will discuss the AACE algorithms.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.